Company Underscores Guidance at Fiscal Year End
Simulations Plus Stock Splits 2-for-1
CEO to be Interviewed by the Wall Street Reporter
Simulations Plus Announces Stock Dividend
Board of Directors Approves Two-for-One Stock Split
Simulations Plus Reports Third Quarter FY2006 Financial Results
Company Sets New Record for Third Quarter Revenues and Earnings
Simulations Plus Reports Preliminary Results for Third Fiscal Quarter
Company CEO to Present at Wall Street Reporter Small-Cap Discovery Conference
Simulations Plus Releases Combined ADMET Predictor and ADMET Modeler Upgrades
Company's Structure-Property Prediction and Model-Building Software Programs Will Be Sold as a Complete Structure-Property Prediction and Modeling Package
Simulations Plus Receives Multo-Year Pharmaceutical Software License
Large Pharmaceutical Company Renews Multi-year License
Simulations Plus Releases GastroPlus(™) 5.1
Important New Improvements Added to the Company's Gold Standard Software
Simulations Plus Reports Second Quarter FY2006 Financial Results
Company Sets New Record for Second Quarter Revenues and Earnings
Simulations Plus Announces Second Quarter 2006 Earnings Conference Call
Conference Call to be on Thursday, April 13, at 4:15 PM EDT
Simulations Plus Releases ClassPharmer 4.0
Dramatic Improvements in Speed and Function Expected to Improve Drug Discovery
Simulations Plus Renews Important Global Software License
Large Customer Renews Annual Global License for GastoPlus ™
Simulations Plus Announces Conference Call Details
Call To Be Held On Tuesday, December 13, at 4:30 PM EST
Simulations Plus Releases GastroPlus TM Version 5.0
Completion of Two-Year Development Program Adds Major New Functionalities
Simulations Plus Requests Extension for 10K-SB Filing
Company Plans Conference Call Shortly After Release
Simulations Plus Announces Change in Investor Relations
Function to be Moved In-House for Greater Operating Efficiency
Simulations Plus Announces Release of New Toxicity Prediction for ADMET Predictor™
hERG Potassium Channel Blocking Affinity Models Important Cardiac Toxicity